Sponsored by Eisai Inc. and Biogen
Advertisement
Articles by Sponsored by Eisai Inc. and Biogen
Advertisement
Latest Updated Articles
Charting New Territories in Early Alzheimer’s Disease: Insights Into A Treating Physician’s Experience with LEQEMBI® (lecanemab-irmb)Published: April 12th 2024 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
2
CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease
3
Epidiolex CBD Treatment Effective Across Range of Developmental Epileptic Encephalopathies
4
AES Presentations Highlight Zorevunersen as Disease-Modifying Treatment for Dravet Syndrome
5
